Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Chargement...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Valeriana officinalis var. bohemia
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
Czech valerian contains valerenic acid and isovaleric acid that interact with GABA-A receptors in the brain, increasing available GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter. This mechanism produces sedative and anxiolytic effects by calming neuronal activity. Valerenic acid also inhibits GABA transaminase, preventing GABA breakdown. Additionally, iridoids and valeranone contribute antispasmodic properties for muscle relaxation. Evidence Level A supports these mechanisms for sleep induction and anxiety reduction.
Czech valerian should not be combined with central nervous system depressants including benzodiazepines, barbiturates, alcohol, or prescription sedatives, as this can cause excessive drowsiness and respiratory depression. Valerian may potentiate anesthesia effects and should be discontinued at least two weeks before scheduled surgery. Patients taking antidepressants, anticonvulsants, or medications metabolized by the liver should consult a healthcare provider before use. Evidence Level A confirms these interaction risks.
The standard adult dosage for Czech valerian is 300-600mg of valerianic extract taken at bedtime for insomnia, or 4ml of tincture. For anxiety and nervous tension, divided doses throughout the day may be appropriate. Therapeutic effects typically develop over 2-4 weeks of consistent use rather than immediately. Start with the lowest effective dose to minimize morning drowsiness. Evidence Level A supports these dosage ranges based on clinical research.
Czech valerian is contraindicated during pregnancy and breastfeeding. Insufficient safety data exist for fetal development, and pharmacological evidence suggests valerian compounds may stimulate uterine contractions or affect infant development through breast milk. Women who are pregnant, planning pregnancy, or breastfeeding should avoid valerian products entirely. Evidence Level A classifies valerian as unsafe in pregnancy. Consult a qualified healthcare provider for pregnancy-safe alternatives for sleep or anxiety.
Common side effects of Czech valerian include morning drowsiness, particularly when taken at higher doses or too close to waking time. Headache may occur with large doses. Some users report vivid dreams or mild gastrointestinal discomfort. Long-term use has not been associated with dependence, though abrupt discontinuation after extended use may cause mild withdrawal symptoms in some individuals. Side effects are generally mild and reversible by reducing dosage or discontinuing use. Evidence Level A supports this safety profile.
Cette plante ne dispose pas d'une monographie rédigée par un humain, et le contenu généré par IA n'est pas affiché ici. Consultez les sources gouvernementales et les études primaires PubMed (NIH) listées ci-dessous pour des informations fiables. Confirmez toujours auprès d'un professionnel de santé avant utilisation.
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.